AddedRisk Factors
The emergence, renegotiation, or expiration of FTAs and other international trade frameworks could adversely affect our competitiveness, supply chain, and financial results.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedRisk Factors
The emergence of new FTAs, the renegotiation of existing FTAs, or the expiration or withdrawal of countries from such frameworks could adversely affect our global competitiveness, supply chain efficiency, and financial performance. Changes in trade terms—such as modified rules of origin, shifts in tariff schedules, new compliance requirements, or uneven enforcement—may alter sourcing economics, disrupt established trade flows, or constrain our ability to optimize production and distribution across regions. These developments could also increase raw‑material or logistics costs, limit market access, or require operational adjustments that may not be fully offset by pricing or mitigation actions. Because these outcomes often arise quickly and vary by jurisdiction, the impact of evolving trade regimes may be difficult to predict and could materially affect our business, results of operations, and cash flows.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedRisk Factors
On July 4, 2025, the U.S. government enacted the One Big Beautiful Bill Act (the “Tax Act”), which includes significant changes to various tax provisions previously enacted by the Tax Cuts and Jobs Act of 2017 (“TCJA”). Among other things, the Tax Act makes permanent extension of certain expiring provisions of TCJA, modifies certain aspects of the international tax framework, and restores favorable tax treatment for certain business provisions. While we have incorporated the impacts of provisions with 2025 effective dates into our provision for income taxes for the quarter, we continue to
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedRisk Factors
evaluate the impact of the Tax Act for future tax years, notably with respect to interest expense deductibility and U.S. taxation of earnings by our non-US subsidiaries.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RemovedRisk Factors
•In connection with our Separation, we were required to assume, and indemnify EID for, certain liabilities. As we may be required to make payments pursuant to these indemnities or under the cost-sharing provisions of the MOU, we may need to divert cash to meet those obligations, and our liquidity or financial results could be negatively affected. In addition, the obligations of EID to indemnify us and/or the obligation of the DuPont Indemnitees to share costs for certain liabilities may not be sufficient to fund us against the full amount of the applicable liabilities for which it will be allocated responsibility, and EID and/or the DuPont Indemnitees may not be able to satisfy their obligations in the future;
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
•We have incurred and expect to continue to incur significant expenses related to the Audit Committee Internal Review, and any resulting litigation.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
•We may experience a disruption of our business activities and our business could be adversely affected due to senior management transitions.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
In March 2024, ECHA published a registration update for trifluoroacetic acid (“TFA”). This update includes a self-classification, by TFA registrants, of Category 2 Reprotoxin. In parallel, Germany has announced its intention to submit a proposal to revise the existing harmonized (legally binding) classification to include reprotoxicity. The proposal will go through a 60-day consultation period to collect comments from interested parties. Next, ECHA’s RAC will review the submission and all comments and adopt an opinion, which could take up to 18 months. Based on this opinion, the European Commission will prepare a legislative proposal in conjunction with Member State experts. If Member States and the European Parliament do not object, the final harmonized classification will then become legally binding after a transition period. There are many variables in this process, which could take years to complete.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
In connection with our Separation, we were required to assume, and indemnify EID for, certain liabilities. As we may be required to make payments pursuant to these indemnities or under the cost-sharing provisions of the MOU, we may need to divert cash to meet those obligations, and our liquidity or financial results could be negatively affected. In addition, the obligations of EID to indemnify us and/or the obligation of the DuPont Indemnitees to share costs for certain liabilities may not be sufficient to fund us against the full amount of the applicable liabilities for which it will be allocated responsibility, and EID and/or the DuPont Indemnitees may not be able to satisfy their obligations in the future.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
Disputes with the DuPont Indemnitees and others, which may arise with respect to the MOU, PFAS matters, indemnification, and/or cost-sharing matters, including disputes based on matter of law or contract interpretation, could materially adversely affect our business, financial condition, results of operations, and cash flows. Multiple lawsuits have been filed by third parties containing allegations that EID’s separation of Chemours was a fraudulent transfer.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
Third parties could also seek to hold us responsible for any of the liabilities of the EID businesses. EID has agreed to indemnify us for such liabilities, but such indemnity from EID may not be sufficient to protect us against the full amount of such liabilities, and EID may not be able to fully satisfy its indemnification obligations. Moreover, even if we ultimately succeed in recovering from EID any amounts for which we are held liable, we may be temporarily required to bear these losses ourselves. Each of these risks could negatively affect our business, financial condition, results of operations, and cash flows.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
The Audit Committee, with the assistance of outside counsel, conducted an internal review in the first quarter of 2024 in response to an anonymous report made to the Chemours Ethics Hotline. The scope of the review included the processes for reviewing reports made to the Chemours Ethics Hotline, our practices for managing working capital, including the related impact on metrics within our incentive plans, certain non-GAAP metrics included in filings made with the SEC or otherwise publicly released, and related disclosures. The Audit Committee completed its planned procedures with respect to its review and its findings determined that our then-Chief Executive Officer ("CEO"), then-Chief Financial Officer ("CFO"), and then-Controller engaged in efforts in the fourth quarter of 2023 to delay payments to certain vendors and accelerate the collection of receivables, in part to meet free cash flow targets that we had communicated publicly, and which also would be part of a key metric for determining incentive compensation applicable to executive officers. The Audit Committee Internal Review determined that there was a lack of transparency with our board of directors by the members of senior management who were engaging in these actions, and that these actions violated the Chemours Code of Ethics for the CEO, CFO, and the Controller. As a result, these individuals are no longer with the Company. We issued Current Reports on Form 8-K related to the Audit Committee Internal Review, including announcing the administrative leave determinations, announcing the appointment of a new CEO and Interim CFO, and providing a general update on the review. Chemours is cooperating with requests for information by the SEC and the United States Attorney’s Office for the Southern District of New York concerning the results of the Audit Committee Internal Review and our SEC filings and in June 2024 received a subpoena from the SEC in respect of that review. In March 2024, two putative class actions were filed in Delaware federal court against us and former officers of the Company alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5. The complaints allege claims on behalf of proposed classes of purchasers of Chemours stock beginning February 10, 2023 and ending February 28, 2024 and seek compensatory damages and fees. In September 2024, an Amended Complaint was filed, and the Company and former officers filed a motion to dismiss the Amended Complaint in October 2024. In April 2024, June 2024, July 2024, August 2024 and October 2024, we received seven stockholder demands for inspection of books and records under Section 220 of the General Corporation Law of the State of Delaware and the common law (“Section 220 Demand”), including in its purpose the investigation of possible wrongdoing, mismanagement or breach of fiduciary duties by the Board of Directors and/or senior management in connection with the compensation of executive officers and oversight over our accounting practices. In addition, we are aware of additional efforts by private law firms to solicit clients in regard to potential securities class action or derivative litigation. These matters could result in us incurring additional costs and liabilities, which may be material to our results of operations, financial condition, and cash flows.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
The Organization of Economic Cooperation and Development, which represents a coalition of member countries globally, is supporting changes to numerous long-standing tax principles through its base erosion and profit shifting (“BEPS”) project. The BEPS project is focused on a number of issues, including the shifting of profits among affiliated entities located in different tax jurisdictions and a global minimum corporate income tax under "Pillar Two". Several jurisdictions in which we operated have enacted Pillar Two rules with an effective date of January 1, 2024. At this time we do not expect a material impact; however, given the scope of our international operations and uncertainty surrounding the impact of future legislation, it is difficult to assess how any changes in tax laws arising from BEPS would impact our income tax expense.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
We have incurred and expect to continue to incur significant expenses related to the Audit Committee Internal Review and the remediation of the material weaknesses in our internal control over financial reporting.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
We may experience a disruption of our business activities and our business could be adversely affected due to senior management transitions.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
We have had several unplanned senior management changes recently, including our then-Chief Executive Officer, then-Chief Financial Officer, and then-Controller being placed on administrative leave in February 2024, and the appointment of our current Chief Executive Officer and Chief Financial Officer. Leadership transitions and management changes can be difficult to manage, particularly if they are unplanned, inherently cause some loss of institutional knowledge and may cause uncertainties or a disruption to our business or increase the likelihood of turnover in key officers and employees. Our ability to execute our business strategies may be impacted by the uncertainty associated with these transitions and the time and attention of our board of directors and management may be required to dedicate to management transitions could disrupt our business. These factors could have a material adverse effect on our results of operations, financial condition, and cash flows.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RewordedRisk Factors
In August 2025, we, EID and the DuPont Indemnitees entered into a PFAS Insurance Proceeds Memorandum of Understanding (“PFAS Insurance MOU”) related to the New Jersey settlement providing for our assignment of certain PFAS-related insurance rights in exchange for funding toward our obligations, Disputes with or among the DuPont Indemnitees and others which may arise with respect to the MOU, PFAS Insurance MOU and PFAS matters, including disputes based on matters of law or contract interpretation, could materially adversely affect our results of operations, financial condition, and cash flows.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our operations operations, products and production facilities are dependent upon attainment and renewal of requisite operating permits and are subject to extensive environmental and health and safety laws, regulations, and enforcements, proceedings or other actions at national, international, and local levels in numerous jurisdictions, relating to pollution, protection of the environment, climate change, transporting and storing raw materials and finished products, storing and disposing of hazardous wastes, and product content and other safety or human rights concerns.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
As discussed further in Part II, Item 9A of this Annual Report on Form 10-K, in 2023 In 2023, we identified certain material weaknesses in our internal control over financial reporting, all of which have been were remediated as of December 31, in 2024.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our success depends on the performance of our ability to attract, retain, and develop our key employees, including our senior management team, which is currently led by a new our Chief Executive Officer. Officer, and to identify and prepare successors for critical roles.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
See also “As a result of the Audit Committee Internal Review, audit committee internal review in 2024, we may be exposed to civil and criminal litigation from investors and/or regulatory entities, entities and significant financial and operational costs, which may adversely affect our reputation, results of operations, financial condition, and cash flows” flows" for a discussion of recent requests for information and potential private litigation.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
We are also subject to requests for information, including those described below under “As a result of the Audit Committee Internal Review, audit committee internal review in 2024, we may be exposed to civil and criminal litigation from investors and/or regulatory entities, entities and significant financial and operational costs, which may adversely affect our reputation, results of operations, financial condition, and cash flows.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
As a result of the Audit Committee Internal Review that commenced audit committee internal review in 2024, we may be exposed to civil and criminal litigation from investors and/or regulatory entities, entities and significant financial and operational costs, which may adversely affect our reputation, results of operations, financial condition, and cash flows.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
To minimize transmission, social and economic restrictions have been or may be imposed in the U.S. and abroad, including travel bans, quarantines, restrictions on public gatherings, shelter-in-place orders, and/or safer-at-home orders.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
We and certain of our customers third parties (e.g., vendors, suppliers and suppliers other service providers) whom we rely on have experienced business and/or supply chain disruptions, plant downtime, power outages, and/or information technology system and network disruptions.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our ability to make scheduled payments on our indebtedness, including on our outstanding notes, to comply with covenants in our debt instruments and to refinance our indebtedness, including on our outstanding notes, depends on and is subject to our financial condition and operating performance, which in turn is affected by general and regional economic, financial, competitive, business, and other factors (many of which are beyond our control), including the availability of financing in the international banking and capital markets.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
We must continue to develop lower-emission manufacturing technologies and identify, develop, and market innovative products or enhance existing products in a disciplined manner and focused on high-return, low-risk initiatives on a timely basis to help us maintain or improve our profit margins and our competitive position.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
While Although we do not foresee any concerns around our currently believe we have adequate liquidity, events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or the financial services industry generally, or concerns about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
Comments were submitted from individuals and organizations during the consultation period in 2023 and the restriction dossier will be is being reviewed by the ECHA Risk Assessment Committee ("RAC") and Socio-economic Analysis Committees (“SEAC”).
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
In January 2026, we, through our subsidiary, The Chemours (Taiwan) Company Limited, entered into the Purchase Agreements with four entities affiliated with each other: Century Wind Power Co., Ltd., Century Iron and Steel Industrial Co., Ltd., Century Huaxin Wind Energy Co., Ltd. and Mr. Lai Wen-Hsiang, to sell ten parcels of land in Kuan Yin, Taiwan, for a total purchase price of approximately $360 million. We anticipate that the sale of the Property will be completed through one or more closings, which are expected to occur by mid-year 2026, subject to the satisfaction of certain closing conditions set forth in the Purchase Agreements and local regulatory approval, inclusive of environmental conditions. We intend to use the cash proceeds from the sale of the Property to reduce the Company’s debt obligations.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
In January 2026, our Washington Works site experienced a disruption that necessitated a temporary shutdown, limiting our capacity at this key manufacturing facility in our Advanced Performance Materials business. This event was traced to equipment affected by a local utility service outage in August of 2025, which is integral to our fluoropolymer supply chain and involves complex chemical processing technology. Although operations have resumed, the unplanned outage coincided with challenging winter weather, resulting in delays to the restart. This unplanned outage is expected to have a negative earnings impact of $20 million to $25 million for APM in the first quarter of 2026.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
As part of our Portfolio Management pillar of our Pathway to Thrive Strategy, in January 2026, we made the strategic decision to temporarily idle one of our mines located in northern Florida and transition to a third-party earth-moving contractor. This revised approach is expected to support our overall cost efforts and promote improved cash generation. Also in our Titanium Technologies business, in February 2026, we welcomed Michael Foley as the new business president.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
On October 15, 2025, we entered into Amendment No. 4 (the “Fourth Amendment”) among the Company, certain subsidiaries of the Company, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent, which amends the Credit Agreement. The Fourth Amendment extended the maturity date of our $1,050 million senior secured U.S. Dollar Term Loan from August 18, 2028 to October 15, 2032. The Fourth Amendment also changed the applicable margin in respect of the Dollar Term Loan to, at our election, adjusted Term Secured Overnight Financing Rate ("SOFR") + 3.50% or adjusted base rate plus 2.50%.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
On October 13, 2025, we entered into a Receivables Purchase Agreement (the "Purchase Agreement") with BNP Paribas Factor GmbH (“BNP”). Pursuant to the Purchase Agreement, and subject to the terms and conditions set forth therein, certain subsidiaries of the Company agreed to offer for sale and to sell, and BNP agreed to purchase, certain eligible receivables and related rights in an amount of up to an aggregate outstanding balance of €180 million. The initial term of the Purchase Agreement extends through October 31, 2026 and will be automatically extended for one-year period, unless earlier terminated in accordance with the terms of the Purchase Agreement.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
The chemicals sector has been and continues to be impacted by changes in U.S. and foreign trade policies, particularly the introduction and adjustment of tariffs by the United States as well as foreign retaliatory tariffs. We actively monitor changes and adjust our operations accordingly to enhance supply chain flexibility, including taking certain pricing actions and evaluating opportunities to source products not directly impacted by existing or potential tariffs. The long-term impact of tariffs, including potential changes to existing tariffs or the imposition of further retaliatory trade measures, on our business, financial condition and results of operations remains uncertain.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
On July 4, 2025, the U.S. government enacted the Tax Act, which includes significant changes to various tax provisions previously enacted by the TCJA. The Tax Act makes permanent extension of certain expiring provisions of TCJA, modifications to the international tax framework, and the restoration of favorable tax treatment for certain business provisions. While we have incorporated the impacts of provisions with 2025 effective dates into our provision for income taxes for the year-ended December 31, 2025, we continue to evaluate the impact of the Tax Act for future tax years, notably with respect to interest expense deductibility and U.S. taxation of earnings by our non-US subsidiaries.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
Valuation allowance require an assessment of both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. Such assessment is required on a jurisdiction-by-jurisdiction basis. The ultimate realization of deferred tax assessment is dependent upon the generation of future taxable income during the periods in which those temporary difference become deductible. Our US federal, state, and foreign valuation allowances are based on projections of taxable income, which may be subject to change in the future, and may be impacted by the Tax Act provisions going into effect in 2026 regarding interest deductibility limitations, and events subsequent to our Balance Sheet date including the previously disclosed sale of land in Kuan Yin, Taiwan and any future costs incurred in connection with Note 22, Commitments and Contingent Liabilities.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
(1)As part of our decision to exit our SPS CapstoneTM business, we incurred accelerated depreciation charges of $23 million during the year ended December 31, 2025, which are included within the "Depreciation and amortization" caption above, and therefore are not included as separate adjustment within this caption.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
In March 2025, the Company entered into Amendment No. 4 to its Amended and Restated Purchase Agreement in respect of its securitization facility to extend the maturity date from March 31, 2025 to March 31, 2028 and decrease the facility limit from $175 million to $165 million.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
In May 2025, the Company entered into the Amendment No. 3 (the "Third Amendment") among the Company, certain subsidiaries of the Company, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent, which amends the Credit Agreement. The Third Amendment increased the total net leverage ratio thresholds governing the applicable rate for the Company’s revolving commitments existing immediately prior to the consummation of the transaction contemplated by the Amendment to May 2, 2030, increased the maximum senior secured net leverage ratio quarterly maintenance test through the fiscal quarter ended September 30, 2026, extended the termination date of certain revolving commitments and increased the aggregate revolving commitments available to $1,000 million, comprised of $780 million in revolving commitments that mature on May 2, 2030 and $220 million in revolving commitments that mature on October 7, 2026; in each case, subject to springing maturity provisions.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
In October 2025, the Company entered into Amendment No. 4 (the “Fourth Amendment”) among the Company, certain subsidiaries of the Company, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent, which amends the Credit Agreement. The Fourth Amendment extended the maturity date of the Company’s $1,050 million senior secured U.S. Dollar Term Loan from August 18, 2028 to October 15, 2032. The Fourth Amendment also changed the applicable margin in respect of the Dollar Term Loan to, at the election of the Company, adjusted Term SOFR + 3.50% or adjusted base rate plus 2.50%.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RemovedMD&A
In November 2024, we issued a $600 million aggregate principal amount of 8.000% senior unsecured notes due January 2033 (the "2033 Notes"). We received proceeds of $591 million, net of underwriting fees and other expenses of $9 million, which are deferred and amortized to interest expense over the term of the 2033 Notes. The net proceeds from the 2033 Notes were used in part to purchase or redeem, as applicable, the euro-denominated 4.000% senior notes of €441 due May 2026.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
Further, concurrently with the offering of the 2033 Notes, we entered into a cross-currency swap to effectively convert the $600 million of the 2033 Notes into a euro-denominated borrowing of €567 million at prevailing euro interest rates, effectively converting the 8.000 USD rate to a fixed Euro rate of 6.160%. The cross-currency swap matures on January 15, 2030.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
In November and December 2024, we completed the first and second amendments to the Credit Agreement, which repriced our Tranche B-3 U.S. Dollar-denominated and Euro-denominated Term Loans, respectively, under its senior secured term loan facility due in August 2028. The First Amendment reduces the applicable margin in respect of our senior secured U.S. dollar-denominated term loan facility from, at our election, adjusted Term SOFR + 3.50% to adjusted Term SOFR + 3.00%, or adjusted base rate plus 2.50% to adjusted base rate plus 2.00%. The Second Amendment reduces the applicable margin in respect of our Euro-denominated term loan facility from adjusted EURIBOR + 4.00% to adjusted EURIBOR + 3.25%. There are no changes to the maturity of the Tranche B-3 U.S. dollar term loan or the Tranche B-3 Euro term loan following these repricing activities, and all other terms are substantially unchanged.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
For the year ended December 31, 2023, the benefit from income taxes was primarily attributable to the net pre-tax loss during the year driven by decreased profitability and certain discrete items in 2023. In 2023, we recorded a $131 million income tax benefit associated with various legal matters, along with a $22 million income tax benefit associated with the Kuan Yin, Taiwan shutdown, inclusive of a $13 million valuation allowance recorded on certain deferred tax assets of one of our Taiwanese subsidiaries and a $13 million benefit associated with a ruling received from Swiss tax authorities in the fourth quarter of 2023. This income tax benefit was offset by $26 million of income tax expense associated with the Glycolic Acid Transaction that occurred in 2023.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
As disclosed in "Note 2 – Basis of Presentation" to the Consolidated Financial Statements, the Audit Committee, conducted with the assistance of independent outside counsel, an internal review, and determined, among other things, that former members of senior management engaged in efforts in the fourth quarter of 2023 to delay payments of up to approximately $100 million, primarily to certain vendors that were originally due to be paid in the fourth quarter of 2023 until the first quarter of 2024; and to accelerate the collection of up to approximately $260 million of receivables into the fourth quarter of 2023 that were originally not due to be received until the first quarter of 2024. The Audit Committee’s review also determined that similar actions, though to a lesser extent, were taken in the fourth quarter of 2022, resulting in a delay of up to approximately $40 million of payments to vendors that were originally due to be paid in the fourth quarter of 2022 until the first quarter of 2023 and the acceleration of the collection of up to approximately $175 million of receivables into the fourth quarter of 2022 that were originally not due to be received until the first quarter of 2023.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
In November 2024, we issued $600 million aggregate principal amount of 8.000% senior unsecured notes due January 2033 (the "2033 Notes"). The net proceeds of the Offering were used to redeem all of our outstanding euro-denominated 4.000% Senior Notes due 2026, which was approximately €441 million (USD $463 million), plus accrued and unpaid interest to, but excluding, the date of redemption, and the remainder of the net proceeds for general corporate purposes.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
In November and December 2024, we completed the first and second amendments to the Credit Agreement, which repriced our Tranche B-3 U.S. Dollar-denominated and Euro-denominated Term Loans, respectively, under its senior secured term loan facility due in August 2028. The First Amendment reduces the applicable margin in respect of our senior secured U.S. dollar-denominated term loan facility from, at our election, adjusted Term SOFR + 3.50% to adjusted Term SOFR + 3.00%, or adjusted base rate plus 2.50% to adjusted base rate plus 2.00%. The Second Amendment reduces the applicable margin in respect of our Euro-denominated term loan facility from adjusted EURIBOR + 4.00% to adjusted EURIBOR + 3.25%. There are no changes to the maturity of the Tranche B-3 U.S. dollar term loan or the Tranche B-3 Euro term loan following these repricing activities, and all other terms are substantially unchanged.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
Further, concurrently with the offering of the senior unsecured notes due January 2033, we entered into a cross-currency swap to effectively convert the $600 million of the senior unsecured notes due January 2033 into a euro-denominated borrowing of €567 million at prevailing euro interest rates. The cross-currency swap matures on January 15, 2030. The cross-currency swap executed on the 2033 notes effectively converts our 8.000% USD rate to a fixed Euro rate of 6.160%.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
(2)USS Lead, East Chicago, Indiana: Although USS Lead, East Chicago, Indiana has a $0 balance as of December 31, 2024, we continue to include this remediation site in the table above due to the accrued environmental remediation liabilities associated with it as of December 31, 2023 for comparable purposes.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
The U.S. Smelter and Lead Refinery, Inc. (“USS Lead”) Superfund site is located in the Calumet neighborhood of East Chicago, Lake County, Indiana. The site includes the former USS Lead facility along with nearby commercial, municipal, and residential areas. The primary compounds of interest are lead and arsenic which may be found in soils within the impacted area. The EPA is directing and organizing remediation on this site, and we are one of a number of parties working cooperatively with EPA on the safe and timely completion of this work. EID’s former East Chicago manufacturing facility was located adjacent to the site, and EID assigned responsibility for the site to us in the Separation Agreement.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
The USS Lead Superfund site was listed on the National Priorities List in 2009. To facilitate negotiations with PRPs, EPA divided the residential part of the USS Lead Superfund site into three zones, referred to as Zone 1, Zone 2, and Zone 3. The division into three zones resulted in Atlantic Richfield Co. (“Atlantic Richfield”) and EID entering into an agreement in 2014 with EPA and the State of Indiana to reimburse EPA’s costs to implement clean-up in Zone 1 and Zone 3. In March 2017, we and three other parties – Atlantic Richfield, EID, and the U.S. Metals Refining Co. (“U.S. Metals”) – entered into an administrative order on consent to reimburse EPA’s costs to clean-up a portion of Zone 2. In March 2018, EPA issued a Unilateral Administrative Order for the remainder of the Zone 2 work to five parties, including us, Atlantic Richfield, EID, U.S. Metals, and USS Lead Muller Group, and these parties entered into an interim allocation agreement to perform that work. As of the end of 2019, the required work in Zone 3 had been completed, and Zone 2 was completed by the end of 2021. The determination of a final allocation for Zone 2 and/or the other Zones is ongoing, and additional PRPs may be identified.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
The environmental accrual for USS Lead includes completion of the remaining obligations under the 2012 Record of Decision (“ROD”) and Statement of Work, which principally encompasses completion of Zone 1. The EPA released a proposed amendment to the 2012 ROD (the “ROD Amendment”) for a portion of Zone 1 in December 2018 (following its August 2018 Feasibility Study Addendum), with its recommended option based on future residential use. The EPA’s ROD Amendment for modified Zone 1 was released in March 2020, and selects as the preferred remedy one which requires a clean-up to residential standards based on the current applicable residential zoning. The ROD Amendment for modified Zone 1 also sets forth a selected contingent remedy which requires clean-up to commercial/industrial standards if the future land use becomes commercial/industrial. In November 2019, a Letter of Intent was executed by the City of East Chicago, Indiana and Industrial Development Advantage, LLC ("IDA"), relating to modified Zone 1 development, and EPA has indicated that it is “more likely” that future land use in this area will be commercial/industrial and not residential.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RewordedMD&A
Year Ended December 31, (Dollars in millions, except per share amounts) 2025 2024 2023 Net sales $ 5,808 $ 5,782 $ 6,078 Cost of goods sold 4,631 4,772 4,906 4,640 Gross profit 1,151 1,306 902 1,142 Selling, general, and administrative expense 585 1,290 799 598 Research and development expense 108 109 108 Restructuring, asset-related, and other charges 59 60 153 Goodwill impairment charge — 56 — Total other operating expenses 810 1,551 966 823 Equity in earnings of affiliates 35 43 45 Interest expense, net (264) (208) (269) (263) Loss on extinguishment of debt (1) (5) (1) Other income, net 26 8 91 Income (loss) (Loss) income before income taxes 127 (318) (277) 106 Provision for (benefit from) income taxes 41 (81) 109 37 Net (loss) income (loss) 86 (237) (386) 69 Less:
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
The increase in our inventories at December 31, 2024 2025 was primarily attributable to an increase in the value of our raw materialinventories due to higher inventories raw materials costs within our Titanium Technologies business business, as well as an increase in line with seasonal demand patterns and higher inventories within our Thermal & Specialized Solutions business business, partially offset by a decrease in advance of plant maintenance activity in the fourth quarter of 2024. inventories within our Advanced Performance Materials business.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
The decrease in our capital expenditures for the year ended December 31, 2024 2025 was primarily attributable to a decrease in capital expenditures in Advanced Performance Materials following completion of capital investments related to PFA capacity expansion, partially offset by an increase in maintenance capital expenditures in Thermal & Specialized Solutions related due to OpteonTM capacity expansion. timing of planned major maintenance and the conclusion of the Corpus expansion project.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
For the year ended December 31, 2024, 2025, our restructuring, asset-related, and other charges were primarily attributable to $27 million of non-cash asset-related charges, $20 million charges of $24 million, employee separation charges of $13 million and $3 million of decommissioning and other charges of $15 million related to the 2024 Restructuring Program initialed in the third quarter of 2024. SPS CapstoneTM Exit.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
The impact of the enactment of We continue to record any changes and impacts related to the Organization for Economic Co-operation and Development Global Anti-Base Erosion Model Rules (“Pillar Two”) is included in our provision for the year ended December 31, 2024; ("Pillar Two"); however, the impact is was not material.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
The decrease in segment net sales for the year ended December 31, 2024 2025 was primarily attributable to a decrease in price of 5%, a decrease in volumes of 3% and unfavorable currency movements which added a 1% headwind to the segment's net sales. 8%, partially offset by an increase in price of 3%.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Pursuant to the binding MOU that we entered into with DuPont, Corteva, and EID in January 2021, costs related to potential future legacy PFAS liabilities arising out of pre-July 1, 2015 conduct will subject to the cost-sharing arrangement, where we bear half of the cost of such future potential legacy PFAS liabilities and DuPont and Corteva will collectively bear the other half of the cost of such future potential legacy PFAS liabilities up to an aggregate $4 billion, of which approximately $2.0 $1.3 billion is available after consideration of the funding of the payment to the State of Ohio Ohio, and supplemental payment to the State of Delaware (discussed below). Delaware, and the net present value of the scheduled settlement payments per the terms of the settlement agreement with the State of New Jersey, described further below.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Our We used $36 million in cash for our financing cash outflows activities during the year ended December 31, 2024, which were primarily attributable to $148 million of cash dividends, partially offset by $116 million of net proceeds received, following the repayment of the 2026 Euro Notes, €450 million 4.000% senior unsecured notes due May 2026, in connection with the issuance of the 8.000% senior unsecured notes due January 2033, as further discussed in “Note 20 – Debt” to the Consolidated Financial Statements.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Our cost of goods sold (“COGS”) decreased other income, net increased by $141 $18 million (or 3%) over 100%) to $4.6 billion $26 million for the year ended December 31, 2024, 2025, compared with COGS other income, net of $4.8 billion $8 million for the same period in 2023. 2024.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
December 31, (Dollars in millions) 2025 2024 2023 Chambers Works, Deepwater, New Jersey $ 73 $ 31 $ 30 Dordrecht Works, Netherlands (1) 30 28 4 Fayetteville Works, Fayetteville, North Carolina 320 351 383 Pompton Lakes, New Jersey 53 41 41 USS Lead, East Chicago, Indiana (2) — 12 Washington Works, West Virginia 24 25 22 All other sites 118 95 98 Total environmental remediation $ 618 $ 571 $ 590
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
The decrease in segment net sales for the year ended December 31, 2024 2025 was primarily attributable to a 5% 6% price decrease, partially offset by as well as a 1% volume increase despite unplanned downtime at our Altamira, Mexico manufacturing site due to extreme drought in the region. decrease.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Our capital expenditures decreased net sales increased by $10 $26 million (or 3%) 0%) to $360 million $5.8 billion for the year ended December 31, 2024, 2025, compared with capital expenditures net sales of $370 million $5.8 billion for the same period in 2023. 2024.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
Quiet changesMD&A
Additionally, if If on December 31, 2028, the balance of the escrow account (including interest) is less than $700 million, the balance of the escrow is to be restored to such amount, with Chemours making 50% of the deposits and DuPont and Corteva together making 50% of the deposits.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new